Paper5901
Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
Rivera-Calimlim L and 3 others. Am J Psychiatry, 1976. Cited by 149 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. Papers, record 5901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5901
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorpromazine | Major topic |
| Psychotic Disorders | Major topic |
| Acute Disease | |
| Adolescent | |
| Adult | |
| Aged | |
| Bipolar Disorder | |
| Brief Psychiatric Rating Scale | |
| Chronic Disease | |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Humans | |
| Middle Aged | |
| Schizophrenia | |
| Trihexyphenidyl |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,477,383 | Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity. | Chem Biol Interact | 2016 | https://conductscience.org/library/papers/26477383 | PubMed |
| 21,847,288 | A study of prophylactic value of antiparkinsonian drug. | Indian J Psychiatry | 1983 | https://conductscience.org/library/papers/21847288 | PubMed |
| 20,919,313 | Neurochemical and psychoanalytical approaches to mania. | Proc R Soc Med | 1977 | https://conductscience.org/library/papers/20919313 | PubMed |
| 8,941,495 | Clinically significant interactions of psychotropic agents with antipsychotic drugs. | Drug Saf | 1996 | https://conductscience.org/library/papers/8941495 | PubMed |
| 7,995,319 | Smoking and body weight influence the clearance of chlorpromazine. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7995319 | PubMed |
| 7,870,930 | Interaction study between remoxipride and biperiden. | Psychopharmacology (Berl) | 1993 | https://conductscience.org/library/papers/7870930 | PubMed |
| 7,656,507 | Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7656507 | PubMed |
| 7,104,178 | Predictive indices for chlorpromazine therapy in schizophrenics. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104178 | PubMed |
| 6,812,119 | Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6812119 | PubMed |
| 6,789,357 | Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6789357 | PubMed |
| 6,787,637 | Fluphenazine pharmacokinetics and therapeutic response. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6787637 | PubMed |
| 6,785,790 | Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6785790 | PubMed |
| 6,768,075 | High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6768075 | PubMed |
| 6,415,733 | Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo. | Psychopharmacology (Berl) | 1983 | https://conductscience.org/library/papers/6415733 | PubMed |
| 6,144,127 | Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6144127 | PubMed |
| 6,119,730 | Differential reversal of various dopamine antagonists by anticholinergics in Sidman avoidance: possible relationship to adrenergic blockade. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6119730 | PubMed |
| 6,111,332 | Assessment of anti-psychotic drugs. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6111332 | PubMed |
| 2,875,481 | Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate. | Psychopharmacology (Berl) | 1986 | https://conductscience.org/library/papers/2875481 | PubMed |
| 2,616,436 | Ventricular fibrillation due to lithium withdrawal--an interaction with chlorpromazine? | Postgrad Med J | 1989 | https://conductscience.org/library/papers/2616436 | PubMed |
| 407,609 | Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion. | Psychopharmacology (Berl) | 1977 | https://conductscience.org/library/papers/407609 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5901
GET https://conductscience.org/api/papers/v1/5901/cited_by?page=2